Thermoplastic nanofluidic devices for biomedical applications.

ABSTRACT: Microfluidics is now moving into a developmental stage where basic discoveries are being transitioned into the commercial sector so that these discoveries can affect, for example, healthcare. Thus, high production rate microfabrication technologies, such as thermal embossing and/or injection molding, are being used to produce low-cost consumables appropriate for commercial applications. Based on recent reports, it is clear that nanofluidics offers some attractive process capabilities that may provide unique venues for biomolecular analyses that cannot be realized at the microscale. Thus, it would be attractive to consider early in the developmental cycle of nanofluidics production pipelines that can generate devices possessing sub-150 nm dimensions in a high production mode and at low-cost

SUBMITTER: Weerakoon-Ratnayake KM 

PROVIDER: S-EPMC5285477 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature